Alexander Oksche
10Patents
2h-index
21Co-inventors
50Inventor score
Filing activity: Sep 5, 2003 → Apr 23, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11020343B2 | Intranasal pharmaceutical dosage forms comprising naloxone | Human Necessities | 4 | Active |
| US9101625B2 | Buprenorphine-wafer for drug substitution therapy | Human Necessities | 3 | Active |
| US9370512B2 | Buprenorphine-wafer for drug substitution therapy | Human Necessities | 2 | Active |
| US7863432B2 | Nucleic acid molecules encoding AKAP18 delta, a splice variant of a protein kinase A anchor protein | Human Necessities | 2 | Expired |
| US11806428B2 | Intranasal pharmaceutical dosage forms comprising naloxone | Human Necessities | 0 | Active |
| US9763931B2 | Buprenorphine-wafer for drug substitution therapy | Human Necessities | 0 | Active |
| US10071089B2 | Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation | Human Necessities | 0 | Active |
| US10898479B2 | Dihydroetorphine for the provision of pain relief and anaesthesia | Chemistry; Metallurgy | 0 | Active |
| US9782359B2 | Opioid composition for treating skin lesions | Human Necessities | 0 | Active |
| US9861628B2 | Buprenorphine-wafer for drug substitution therapy | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.